Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Teva
Medtronic
Harvard Business School
Colorcon
Dow
Cipla
Chinese Patent Office
AstraZeneca

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,284,804

« Back to Dashboard

Which drugs does patent 6,284,804 protect, and when does it expire?

Patent 6,284,804 protects CIPRODEX and is included in one NDA.

This patent has twenty-two patent family members in twenty countries.
Summary for Patent: 6,284,804
Title: Topical suspension formulations containing ciprofloxacin and dexamethasone
Abstract:Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.
Inventor(s): Singh; Onkar N. (Arlington, TX), Bhagat; Haresh G. (Fort Worth, TX)
Assignee: Alcon Universal Ltd. (Hunenberg, CH)
Application Number:09/636,563
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 6,284,804

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis Pharms Corp CIPRODEX ciprofloxacin; dexamethasone SUSPENSION/DROPS;OTIC 021537-001 Jul 18, 2003 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,284,804

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,359,016 Topical suspension formulations containing ciprofloxacin and dexamethasone ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,284,804

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 776609 ➤ Try a Free Trial
Argentina 025661 ➤ Try a Free Trial
Austria 252887 ➤ Try a Free Trial
Australia 7057000 ➤ Try a Free Trial
Brazil 0014203 ➤ Try a Free Trial
Canada 2379605 ➤ Try a Free Trial
China 1376054 ➤ Try a Free Trial
China 1158994 ➤ Try a Free Trial
Germany 60006262 ➤ Try a Free Trial
European Patent Office 1214056 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Harvard Business School
Medtronic
Deloitte
Daiichi Sankyo
Teva
Queensland Health
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot